Thomas S. Kilduff, Ph.D. is Director of the Center for Neuroscience in the Biosciences Division at the non-profit SRI International in Menlo Park, California.  He is co-discoverer of the hypothalamic neuropeptide hypocretin (also known as orexin), a key neurotransmitter in the maintenance of wakefulness.  More recently, his laboratory has identified a population of cortical interneurons that are activated during sleep in proportion to homeostatic sleep drive.  In addition to research on the neural circuitry that controls sleep and wakefulness, his laboratory is also focused on development of pharmacotherapeutics for sleep disorders such as insomnia and narcolepsy and use of the EEG as a biomarker in animal models of neurological/neuropsychiatric disorders.  Tom received his MS and PhD degrees from Stanford University where he was a Danforth Foundation Fellow, a National Science Foundation Fellow, and a Grass Foundation Fellow at the Marine Biological Laboratory in Woods Hole.  Upon completion of his PhD, he became a National Academy of Sciences–National Research Council Research Associate at NASA-Ames Research Center before he joined the Stanford University Sleep Disorders Research Center.  In 1999, he founded the Sleep Neurobiology Program at SRI International and was appointed to direct the Center for Neuroscience in 2008.  In addition to service on Review Committees for the NIH and several foundations, he has been a Consulting Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and held multiple elected offices in the Sleep Research Society (SRS) including TEAC Chair and Secretary-Treasurer.  He has also served on the Executive Boards of the SRS, the SRS Foundation, and the Associated Professional Sleep Societies. He is an AAAS Fellow, an SRI International Fellow, a Fellow of the American College of Neuropsychopharmacology, was a Pfizer Neuroscience Visiting Scholar and received the Distinguished Scientist Award from the Sleep Research Society.